Nasdaq
Entity.
- Evidence
- 2,345 documents · 185 separate publishers
- Standing
- A name from our starting list; its record is kept up to date automatically from coverage
- Time
- first seen 29 Apr 2026, last seen 8 Oct 2026
- Measured
- 26% of mentions say something specific about it; the rest only name it
- As of
- 8 Oct 2026
Where this comes from
- Hindustan Times Business · 2026-10-07 · Why are Dow, S&P 500 and Nasdaq falling as Treasury yields hit 24-year high? (opens the source in a new tab)
- analyticsinsight · 2026-10-07 · US Stock Market: S&P 500, Nasdaq Futures Retreat After Record Highs as Oil, Yields Climb (opens the source in a new tab)
- EUROMETAL · 2026-10-07 · Trasteel moves closer to Nasdaq listing via SPAC (opens the source in a new tab)
- MarketBeat News Feed · 2026-10-07 · Sarepta Therapeutics (NASDAQ:SRPT) Downgraded by Zacks Research to "Strong Sell" (opens the source in a new tab)
- The Business Times · 2026-10-07 · S&P 500, Nasdaq reach record closing highs as focus pivots to earnings (opens the source in a new tab)
- The Crypto Times · 2026-10-07 · Ripple-Backed Evernorth Sets XRPN Nasdaq Debut for Oct 12 After Delay (opens the source in a new tab)
- News Archives · 2026-10-07 · Ripple News: Will Evernorth’s XRPN Debut on Nasdaq This Oct 12? (opens the source in a new tab)
- Crowdfund Insider · 2026-10-07 · Nasdaq’s Fintech focused Business Now Experiencing Recurring-Revenue Growth (opens the source in a new tab)
- TradingView Ideas · 2026-10-07 · NASDAQ BULL (opens the source in a new tab)
- Yellow.com · 2026-10-07 · Evernorth Readies 473M XRP For Nasdaq, Will Stock Buyers Back The Treasury Bet? (opens the source in a new tab)
- MarketBeat News Feed · 2026-10-06 · X4 Pharmaceuticals (NASDAQ:XFOR) CFO David Kirske Sells 11,767 Shares of Stock (opens the source in a new tab)
What is claimed about it
- Corroborated: Reported by three or more sources that did not copy each other.
- Reported by two: Reported by two sources that did not copy each other.
- Single source: Reported by one source so far.
- Ripple-Backed Evernorth Sets XRPN Nasdaq Debut for Oct 12 After Delay Reported by two · first reported 7 Oct 2026
- US Stock Market: S&P 500, Nasdaq Futures Retreat After Record Highs as Oil, Yields Climb Corroborated · first reported 6 Oct 2026
- Insider Selling: Recursion Pharmaceuticals (NASDAQ:RXRX) Director Sells 25,000 Shares of Stock Single source · first reported 3 Oct 2026
- Evernorth shareholders approve $1 billion XRP treasury deal, clearing path to Nasdaq debut Corroborated · first reported 1 Oct 2026
- PowerBank Corporation Receives Additional 180-day Compliance Period from Nasdaq to Regain Compliance with Minimum Bid Price Requirement Single source · first reported 30 Sept 2026
- Meta is pushing its AI agent into small businesses and hired a database veteran to run it Corroborated · first reported 29 Sept 2026
- Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) Stock Has Consensus Price Target of $34.58 According to Analysts Single source · first reported 26 Sept 2026
- Paramount To Move Its Class B Shares From Nasdaq To New York Stock Exchange In Early October Reported by two · first reported 25 Sept 2026
- Jazz Pharmaceuticals (NASDAQ:JAZZ) Stock Rating Upgraded by The Goldman Sachs Group Single source · first reported 25 Sept 2026
Situations it is named in
- Funding round: Krakena situation that names it